CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year gross profit growth rate
Latest
-131.39%
↓ 55% below average
Average (9y)
-84.59%
Historical baseline
Range
High:402.17%
Low:-714.67%
CAGR
-17.2%
Structural decline
| Period | Value |
|---|---|
| 2024 | -131.39% |
| 2023 | 318.32% |
| 2022 | -113.53% |
| 2021 | 402.17% |
| 2020 | -343.76% |
| 2019 | 199.62% |
| 2018 | -284.16% |
| 2017 | 22.31% |
| 2016 | -200.78% |
| 2015 | -714.67% |